Granisetron Transdermal Patch

281 interactions 403 cited references
Also sold as: Sancuso Sancuso®
About Granisetron Transdermal Patch

Granisetron transdermal patches are used to prevent nausea and vomiting caused by chemotherapy. Granisetron is in a class of medications called 5HT3 inhibitors. It works by blocking serotonin, a natural substance in the body that causes nausea and vomiting. Read the full Granisetron Transdermal Patch drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Phenelzine Pimozide Piperaquine Saquinavir Sparfloxacin Terfenadine
16 Contraindicated 265 Major
All (281) Contraindicated (16) Major (265)

Major

Granisetron Transdermal Patch Flecainide Tambocor® An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Fluoxetine RECONCILE Increased risk of serotonin syndrome and QT-interval prolongation Details Granisetron Transdermal Patch Fluvoxamine Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Formoterol Perforomist Increased risk of QT interval prolongation and an increased risk of cardiovascular adverse effects Details Granisetron Transdermal Patch Foscarnet Foscavir Increased risk of QT interval prolongation Details Granisetron Transdermal Patch Fosfomycin Contepo An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Fosphenytoin Cerebyx An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Fostemsavir Rukobia Increased risk of torsade de pointes Details Granisetron Transdermal Patch Frovatriptan Frova Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Furazolidone Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Gatifloxacin Zymaxid Increased risk of QT interval prolongation and torsade de pointes Details Granisetron Transdermal Patch Gemifloxacin Factive An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Gepirone Exxua Increased risk of serotonin syndrome and an increased risk of QT interval prolongation and cardiac arrhythmias Details Granisetron Transdermal Patch Gepotidacin Blujepa An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Givinostat Duvyzat Increased risk of QT interval prolongation and torsade de pointes Details Granisetron Transdermal Patch Glasdegib Daurismo Increased risk of QT interval prolongation Details Granisetron Transdermal Patch Goserelin Increased risk of QT interval prolongation Details Granisetron Transdermal Patch Halofantrine An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Haloperidol An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Histrelin Supprelin Increased risk of QT interval prolongation Details Granisetron Transdermal Patch Hydrocodone Hysingla An increased risk of serotonin syndrome Details Granisetron Transdermal Patch Hydromorphone Dilaudid Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Hydroxyamphetamine An increased risk of serotonin syndrome Details Granisetron Transdermal Patch Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Granisetron Transdermal Patch Hydroxytryptophan Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Hydroxyzine An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Ibutilide Corvert An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Iloperidone Fanapt Increased risk of QT interval prolongation and torsade de pointes Details Granisetron Transdermal Patch Imipramine Increased risk of serotonin syndrome and QT-interval prolongation Details Granisetron Transdermal Patch Inotuzumab Ozogamicin Besponsa Increased risk of QT interval prolongation Details Granisetron Transdermal Patch Iproniazid Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Isocarboxazid Marplan Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Isoflurane Fluriso An increased risk of QT interval prolongation and torsade de pointes Details Granisetron Transdermal Patch Itraconazole Sporanox An increased risk of QT interval prolongation and torsade de pointes Details Granisetron Transdermal Patch Ivabradine Corlanor Increased risk of QT prolongation Details Granisetron Transdermal Patch Ivosidenib Tibsovo An increased risk of QT interval prolongation Details Granisetron Transdermal Patch Ketobemidone Increased risk of serotonin syndrome Details Granisetron Transdermal Patch Ketoconazole Extina Increased risk of QT interval prolongation Details Granisetron Transdermal Patch Kratom An increased risk of serotonin syndrome Details Granisetron Transdermal Patch Lapatinib Tykerb An increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.